Differences in invasive capacity of endometrial cancer cell lines expressing different progesterone receptor isotypes: possible involvement of cadherins

J Soc Gynecol Investig. 2005 May;12(4):278-84. doi: 10.1016/j.jsgi.2005.01.030.

Abstract

Objective: Loss of expression of progesterone receptors (PR) in endometrial cancer is related to a more invasive and metastatic phenotype. In this study we aim to investigate whether selective loss of PRA or PRB affects the invasive capacity of endometrial cancer cells.

Methods: cDNA microarrays were performed to compare gene expression profiles of a set of endometrial cancer sub-cell lines expressing PRA and/or PRB. In vitro invasion assays were performed to assess whether differences in gene expression between the lines were reflected by their invasive behavior.

Results: It was observed that cell lines that express only PRA express higher levels of cadherins, and show a lower level of invasion compared to cell lines that express PRB. When cadherin function was inhibited in exclusively PRA-expressing cell lines, an increase of in vitro invasion was observed. In support of these findings, it was observed that in higher grade and more invasive endometrial cancer, expression of E-cadherin decreased.

Conclusions: These results indicate that relative loss of PRA during progression of endometrial cancer can have a negative impact on cadherin expression, which may lead to development of a more metastatic phenotype.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Western
  • Cadherins / biosynthesis
  • Endometrial Neoplasms / pathology*
  • Female
  • Gene Expression Profiling
  • Humans
  • Immunohistochemistry
  • Neoplasm Invasiveness / genetics*
  • Neoplasm Invasiveness / physiopathology*
  • Neoplasm Metastasis
  • Oligonucleotide Array Sequence Analysis
  • Phenotype
  • Receptors, Progesterone / biosynthesis*
  • Tumor Cells, Cultured

Substances

  • Cadherins
  • Receptors, Progesterone
  • progesterone receptor A
  • progesterone receptor B